Regenerx Biopharmaceuticals Inc
RGRXD
Revenue
19.19k
▲1.00▲0.005211%
3 Months ChangeAssets
186.81k
▼-195.37k▼-51.12%
3 Months ChangeLiabilities
3.93M
▲103.50k▲2.70%
3 Months ChangeFree Cash Flow
-1.07M
▼-286.53k▼-36.66%
36 Months ChangeRevenue/Cost Of Revenue
Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Cost Of Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Revenue
was reported to be 0.00 on 0000-00-00. Compared to last quarter, this is an increase of 0.00 (0.00%).Similarly the
Cost Of Revenue
was 0.00 on 0000-00-00. This comes down to an increase of 0.00 (0.00%).Revenue
Cost Of Revenue
No Data
Date | Revenue | Cost Of Revenue |
---|---|---|
No Data |
Net Profit/Loss
Net Profit/Loss
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Net Profit/Loss
Baseline
No Data
Date | Net Profit/Loss |
---|---|
No Data |
Assets/Liabilities
Assets
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Liabilities
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Assets
was reported to be 0.00 on 0000-00-00. Compared to last quarter, this is an increase of 0.00 (0.00%).Similarly the
Liabilities
was 0.00 on 0000-00-00. This comes down to an increase of 0.00 (0.00%).Assets
Liabilities
No Data
Date | Assets | Liabilities |
---|---|---|
No Data |
Cash Flows
Operating (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Investing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Financing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Free Cash Flow
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Operating (Cash Flow)
was reported to be 0.00 on 0000-00-00. Compared to last quarter, this is an increase of 0.00 (0.00%).Similarly the
Investing (Cash Flow)
was 0.00 on 0000-00-00. This comes down to an increase of 0.00 (0.00%).The
Financing (Cash Flow)
was 0.00 and resulted in an increase of 0.00 (0.00%).Free Cash Flow
was 0.00; an increase of 0.00 (0.00%).Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
No Data
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
No Data |
EPS
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
EPS (Diluted)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
EPS
was reported to be 0.00 on 0000-00-00. Compared to last quarter, this is an increase of 0.00 (0.00%).Similarly the
EPS (Diluted)
was 0.00 on 0000-00-00. This comes down to an increase of 0.00 (0.00%).EPS
EPS (Diluted)
No Data
Date | EPS | EPS (Diluted) |
---|---|---|
No Data |
Outstanding Shares
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Outstanding Shares
No Data
Date | Outstanding Shares |
---|---|
No Data |
Recent 8-K/10-Q Filings
2023-08-07
Form 8-K
ID: 0001104659-23-088321
2023-07-10
Form 8-K
ID: 0001104659-23-079709
2023-06-21
Form 8-K
ID: 0001104659-23-072992
2023-05-15
Form 10-Q
ID: 0001410578-23-001223
2022-11-14
Form 10-Q
ID: 0001410578-22-003350
2022-08-12
Form 10-Q
ID: 0001410578-22-002406
2022-05-16
Form 10-Q
ID: 0001410578-22-001705
2021-11-15
Form 10-Q
ID: 0001104659-21-139207
2021-11-15
Form 8-K
ID: 0001104659-21-139018
2021-08-06
Form 10-Q
ID: 0001104659-21-101442